therapeutic 4,093 words KG: neuroprotection
Contents

Neuroprotection Strategies in Neurodegeneration

💊 Therapeutic Info
Nameneuroprotection
Key Genes/ProteinsAkt, AKT, ALOX15, AMPK, APOE, APOE2
Related DiseasesAlzheimer's Disease
Related Pathwaysamyloid clearance, astrocyte-specific complement inhibition

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (167)

Prefrontal sensory gating circuit restoration via PV interne
Score: 0.78
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.68
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.67
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.65
Programmable Neuronal Circuit Repair via Epigenetic CRISPR
Score: 0.63
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.62
Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.62
TREM2-Dependent Microglial Senescence Transition
Score: 0.62
Restoring Neuroprotective Tryptophan Metabolism via Targeted
Score: 0.61
Complement-Mediated Synaptic Pruning Dysregulation
Score: 0.61
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.61
The Glial Ketone Metabolic Shunt Hypothesis
Score: 0.61
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
← Prevpg 8/9Next →

Related Analyses (30)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40

See Also (15)

Swedish BioFINDER 2 Study: Biomarkers and Neurodegenera
clinical · Pages share 135 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 135 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 26 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 135 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 135 hypotheses

Knowledge Graph (12 edges)

vagal_signaling_pathway activates neuroprotection
PI3K/Akt/mTOR activates neuroprotection
microglial efferocytosis activates neuroprotection
BECN1 activates neuroprotection
autophagy activates neuroprotection
plant-derived secondary metabolites activates neuroprotection
integrated stress response activates neuroprotection
AKT associated_with neuroprotection
PI3K/AKT enhances neuroprotection
microglial APOE4 deletion promotes neuroprotection

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.